Raleigh, NC – According to filings with the U.S. Securities and Exchange Commission, 9 Meters Biopharma is raising $22,565,371.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, Edward Sitar played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About 9 Meters Biopharma

9 Meters Biopharma, Inc. is a rare, orphan and unmet needs focused GI company. The Company is advancing drug candidates for short bowel syndrome and celiac disease. 9 Meters is led by a strong management team with a history of bringing novel therapeutics to market, and the Company owns all global rights to their products, which are backed by more than 150 patents worldwide.

To learn more about 9 Meters Biopharma, visit http://9meters.com/

Contact:
Edward Sitar, Chief Financial Officer
919-485-8080
https://www.linkedin.com/in/edsitar/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved